Vertex Pharmaceuticals Incorporated (VRTX) Balance Sheet: Assets & Liabilities

Vertex Pharmaceuticals Incorporated (VRTX) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Vertex Pharmaceuticals Incorporated reported total assets of $25.64B and total liabilities of $6.98B. Shareholders' equity was $18.67B, up 13.7% from $16.41B a year earlier. Total debt stood at $2.04B against $6.61B in cash and short-term investments, a net cash position of $4.57B. That puts debt-to-equity at 0.11, compared with 0.11 a year earlier.

Vertex Pharmaceuticals Incorporated Balance Sheet Analysis

Values in billions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Vertex Pharmaceuticals Incorporated (VRTX) - Annual data in billions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Current Assets
Cash and Cash Equivalents	5.08	4.57	10.37	10.50	6.80	5.99	3.11	2.65	1.67
Short-Term Investments	1.52	1.55	0.85	0.27	0.73	0.67	0.70	0.52	0.42
Cash & Short-Term Investments	6.61	6.12	11.22	10.78	7.52	6.66	3.81	3.17	2.09
Accounts Receivable	2.05	1.61	1.56	1.44	1.14	0.89	0.63	0.41	0.39
Inventory	1.69	1.21	0.74	0.46	0.35	0.28	0.17	0.12	0.11
Other Current Assets	0.11	0.08	0.62	0.55	0.55	0.31	0.21	0.14	0.06
Total Current Assets	11.20	9.60	14.14	13.23	9.56	8.13	4.82	3.84	2.65
Non-Current Assets
Property, Plant & Equipment (Net)	3.08	2.58	1.45	1.46	1.42	1.28	0.83	0.81	0.79
Long-Term Investments	5.81	5.11	2.50	0.11	0.00	0.00	0.00	0.00	0.02
Goodwill	1.09	1.09	1.09	1.09	1.00	1.00	1.00	0.05	0.05
Intangible Assets	0.42	0.83	0.84	0.60	0.40	0.40	0.40	0.00	0.03
Other Non-Current Assets	1.24	1.00	0.90	0.41	1.05	0.05	0.07	0.04	0.01
Total Non-Current Assets	14.44	12.94	8.59	4.92	3.87	3.62	3.50	2.40	0.90
Total Assets	25.64	22.53	22.73	18.15	13.43	11.75	8.32	6.25	3.55
Current Liabilities
Accounts Payable	0.46	0.41	0.36	0.30	0.20	0.16	0.09	0.11	0.07
Short-Term Debt	0.08	0.09	0.08	0.09	0.08	0.10	0.04	0.01	0.02
Accrued Liabilities	2.59	2.36	2.66	1.79	1.68	-	-	-	-
Deferred Revenue	0.17	0.21	0.17	0.16	0.17	0.19	0.06	0.02	0.24
Other Current Liabilities	0.13	0.04	2.83	2.07	0.27	1.33	1.07	0.98	0.47
Total Current Liabilities	3.86	3.56	3.55	2.74	2.14	1.88	1.33	1.12	0.81
Non-Current Liabilities
Long-Term Debt	1.95	1.66	0.72	0.81	0.89	0.89	0.62	0.58	0.58
Deferred Tax Liabilities	1.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01
Other Non-Current Liabilities	0.27	0.20	0.88	0.69	0.30	0.30	0.19	0.03	0.03
Total Non-Current Liabilities	3.12	2.56	1.60	1.50	1.19	1.19	0.90	0.69	0.70
Total Liabilities	6.98	6.12	5.15	4.24	3.33	3.07	2.23	1.81	1.50
Stockholders' Equity
Common Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Retained Earnings	13.56	9.61	10.14	6.52	3.20	0.86	-1.85	-2.99	-5.12
Accumulated Other Comprehensive Income	-0.02	0.13	-0.01	0.00	0.02	-0.07	0.00	0.00	-0.01
Additional Paid-in Capital	5.12	6.67	7.45	7.39	6.88	7.89	7.94	7.42	7.16
Minority Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01
Shares Outstanding	0.25	0.26	0.26	0.26	-	-	-	-	-
Total Stockholders' Equity	18.67	16.41	17.58	13.91	10.10	8.69	6.09	4.44	2.03
Total Liabilities & Equity	25.64	22.53	22.73	18.15	13.43	11.75	8.32	6.25	3.55

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Vertex Pharmaceuticals Incorporated Balance Sheet

How much debt does Vertex Pharmaceuticals Incorporated have?

Vertex Pharmaceuticals Incorporated had total debt of $2.04B as of Dec 31, 2025, against $6.61B in cash and short-term investments. Its debt-to-equity ratio was 0.11. Total debt was $1.75B a year earlier.

What are Vertex Pharmaceuticals Incorporated's total assets?

Vertex Pharmaceuticals Incorporated reported total assets of $25.64B as of Dec 31, 2025, up 13.8% from $22.53B a year earlier. Total liabilities were $6.98B.

What is Vertex Pharmaceuticals Incorporated's shareholders' equity?

Vertex Pharmaceuticals Incorporated's shareholders' equity was $18.67B as of Dec 31, 2025, or about $73.49 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition